Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of ...

Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the ...

New wireless standard: Wi-Fi 8 offers relief from congestion

Even though it will likely be another year until the adoption of Wi-Fi 8, also known as IEEE 802.11bn, first router ...

Addex Therapeutics: Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

Cumulus Neuroscience Publishes Data Validating a Scalable Measurement of Neuroplasticity Using Low-Burden Dry Sensor EEG

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of its latest peer-reviewed paper in Scientific Reports: "A brief visual ...
Game Rant

Best Frequency Modulation Box Farm Locations in ARC Raiders

Mohsen Baqery is a Guide Staff Writer from Turkey. With a passion for gaming that borders on obsession, Mohsen thrives on guiding fellow gamers through the most challenging obstacles while exploring ...
The New York Times

Mamdani Says He Would Phase Out N.Y.C. Gifted Program for Early Grades

Zohran Mamdani, the Democratic front-runner in the mayor’s race, plans if elected to replace the selective program, which became a symbol of segregation in public schools. By Emma G. Fitzsimmons and ...
Electronic Design

Advanced Modulation Techniques: The Key to Improved Power Density?

Doing more with less in electronics often means improving power density. One of the new areas garnering attention involves applying a variety of advanced modulation techniques, including PWM and space ...
Business Wire

Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedema Phase IIb trial to ...
ascopubs.org

METANOVA: A phase II trial of metastasis-directed radiotherapy for de novo oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE ...

PSMA-delay castration (DC): An open-label, multicenter, randomized phase 3 study of [177Lu]Lu-PSMA-617 versus observation in patients with metachronous PSMA-positive oligometastatic prostate cancer ...
The New England Journal of Medicine

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...
PV Tech

Grenergy sells first three phases of Oasis de Atacama project, secures financing for phase three

Phases 1-3 of the Oasis de Atacama project in Chile will have a combined capacity of 451MW for solar PV and 2.5GWh for BESS. Image: Grenergy. Spanish independent power producer (IPP) Grenergy has sold ...